ArticleMolecular pharmaceutics2020

Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.

Alexander A Svoronos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.